SCHEMBL27809084

SCHEMBL27809084

CN(C(=O)c1ccccc1)c1ccc(CC2COC(C)(C)OC2C(=O)C=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
TMEM97 Q5BJF2 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
TBXA2R P21731 1/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
CYP26B1 Q9NR63 1/20 0.36
HTT P42858 1/20 0.36
MAOA P21397 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PGR P06401 1/20 0.36
NR1H4 Q96RI1 1/20 0.35
ACACB O00763 1/20 0.35
KDM1A O60341 1/20 0.34
MAOB P27338 1/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28061650 0.79 TMEM97 (0.35) TMEM97SIGMAR1TBXA2RKMT2AKDM4E
SCHEMBL28124735 0.79 HCRTR2 (0.38) TMEM97SIGMAR1TBXA2RHTTALDH1A1
SCHEMBL28125140 0.77 GLA (0.43) KMT2AKDM4EALDH1A1SMN1; SMN2HIF1A
SCHEMBL28061680 0.76 LTB4R (0.38) TMEM97SIGMAR1TBXA2RMAOBTBXAS1
SCHEMBL28067355 0.74 MMP9 (0.44) ACACB
SCHEMBL28061646 0.73 KDM4E (0.38) TMEM97SIGMAR1KDM4EALDH1A1
SCHEMBL3101144 0.71 GLA (0.50) EGFRERBB2NR1H2NR1H3CYP26B1
SCHEMBL28061679 0.71 P2RX3 (0.40) KMT2AMAOB
SCHEMBL28093132 0.71 SMN1; SMN2 (0.39) HTTKDM4EALDH1A1SMN1; SMN2NPC1
SCHEMBL28093453 0.70 CYP2A6 (0.39) TBXA2RTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101784520-A Novel malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORP 2010-07-21 CN disclosed